XML 25 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
3 Months Ended
Mar. 31, 2012
Mar. 31, 2011
Cash flows from operating activities:    
Net income (loss) $ 153 $ (63)
Depreciation and amortization 820 0
Amortization of deferred financing costs 12 0
Changes in assets and liabilities:    
Accounts receivable and other assets 269 (5)
Accounts payable and accrued expenses (94) 11
Other liabilities 4 0
Net cash from operating activities 1,164 (57)
Cash flows from investing activities:    
Capital expenditures (260) 0
Increase in restricted cash (132) 0
Net cash from investing activities (392) 0
Cash flows from financing activities:    
Proceeds from issuance of preferred stock 101 0
Proceeds from issuance of common stock 3,000 0
Payments for deferred financing costs (3) 0
Distributions on common stock (3) 0
Distributions to non-controlling interests (760) 0
Net cash from financing activities 2,335 0
Net change in cash and cash equivalents 3,107 (57)
Cash and cash equivalents, beginning of period 1,107 209
Cash and cash equivalents, end of the period $ 4,214 $ 152